Cancer stem cell definitions and terminology: the devil is in the details - PubMed (original) (raw)
Review
. 2012 Nov;12(11):767-75.
doi: 10.1038/nrc3368. Epub 2012 Oct 11.
Dominique Bonnet, Ruggero De Maria, Tsvee Lapidot, Mhairi Copland, Junia V Melo, Christine Chomienne, Fumihiko Ishikawa, Jan Jacob Schuringa, Giorgio Stassi, Brian Huntly, Harald Herrmann, Jean Soulier, Alexander Roesch, Gerrit Jan Schuurhuis, Stefan Wöhrer, Michel Arock, Johannes Zuber, Sabine Cerny-Reiterer, Hans E Johnsen, Michael Andreeff, Connie Eaves
Affiliations
- PMID: 23051844
- DOI: 10.1038/nrc3368
Review
Cancer stem cell definitions and terminology: the devil is in the details
Peter Valent et al. Nat Rev Cancer. 2012 Nov.
Abstract
The cancer stem cell (CSC) concept has important therapeutic implications, but its investigation has been hampered both by a lack of consistency in the terms used for these cells and by how they are defined. Evidence of their heterogeneous origins, frequencies and their genomic, as well as their phenotypic and functional, properties has added to the confusion and has fuelled new ideas and controversies. Participants in The Year 2011 Working Conference on CSCs met to review these issues and to propose a conceptual and practical framework for CSC terminology. More precise reporting of the parameters that are used to identify CSCs and to attribute responses to them is also recommended as key to accelerating an understanding of their biology and developing more effective methods for their eradication in patients.
Similar articles
- Are all cancer stem cells created equal?
Xie X, Teknos TN, Pan Q. Xie X, et al. Stem Cells Transl Med. 2014 Oct;3(10):1111-5. doi: 10.5966/sctm.2014-0085. Epub 2014 Aug 13. Stem Cells Transl Med. 2014. PMID: 25122687 Free PMC article. Review. - Engineering cancer stem-like cells from normal human lung epithelial cells.
Sasai K, Takao-Rikitsu E, Sukezane T, Yanagita E, Nakagawa H, Itoh-Yagi M, Izumi Y, Itoh T, Akagi T. Sasai K, et al. PLoS One. 2017 Apr 5;12(4):e0175147. doi: 10.1371/journal.pone.0175147. eCollection 2017. PLoS One. 2017. PMID: 28380052 Free PMC article. - Tumor heterogeneity and cancer stem cell paradigm: updates in concept, controversies and clinical relevance.
Singh AK, Arya RK, Maheshwari S, Singh A, Meena S, Pandey P, Dormond O, Datta D. Singh AK, et al. Int J Cancer. 2015 May 1;136(9):1991-2000. doi: 10.1002/ijc.28804. Epub 2014 Mar 4. Int J Cancer. 2015. PMID: 24615680 Review. - Dynamic regulation of cancer stem cells and clinical challenges.
Ni C, Huang J. Ni C, et al. Clin Transl Oncol. 2013 Apr;15(4):253-8. doi: 10.1007/s12094-012-0927-7. Epub 2012 Aug 28. Clin Transl Oncol. 2013. PMID: 22926945 Review. - Breast-cancer stem cells-beyond semantics.
Badve S, Nakshatri H. Badve S, et al. Lancet Oncol. 2012 Jan;13(1):e43-8. doi: 10.1016/S1470-2045(11)70191-7. Lancet Oncol. 2012. PMID: 22225725 Review.
Cited by
- Cancer Stem Cells in Oral Squamous Cell Carcinoma: A Narrative Review on Experimental Characteristics and Methodological Challenges.
Acharya SK, Shai S, Choon YF, Gunardi I, Hartanto FK, Kadir K, Roychoudhury A, Amtha R, Vincent-Chong VK. Acharya SK, et al. Biomedicines. 2024 Sep 16;12(9):2111. doi: 10.3390/biomedicines12092111. Biomedicines. 2024. PMID: 39335624 Free PMC article. Review. - VDAC1-Based Peptides as Potential Modulators of VDAC1 Interactions with Its Partners and as a Therapeutic for Cancer, NASH, and Diabetes.
Shteinfer-Kuzmine A, Santhanam M, Shoshan-Barmatz V. Shteinfer-Kuzmine A, et al. Biomolecules. 2024 Sep 9;14(9):1139. doi: 10.3390/biom14091139. Biomolecules. 2024. PMID: 39334905 Free PMC article. Review. - Epigenetic modification of ferroptosis by non-coding RNAs in cancer drug resistance.
Wang H, Fleishman JS, Cheng S, Wang W, Wu F, Wang Y, Wang Y. Wang H, et al. Mol Cancer. 2024 Aug 27;23(1):177. doi: 10.1186/s12943-024-02088-7. Mol Cancer. 2024. PMID: 39192329 Free PMC article. Review. - Competing endogenous RNAs regulatory crosstalk networks: The messages from the RNA world to signaling pathways directing cancer stem cell development.
Aria H, Azizi M, Nazem S, Mansoori B, Darbeheshti F, Niazmand A, Daraei A, Mansoori Y. Aria H, et al. Heliyon. 2024 Jul 26;10(15):e35208. doi: 10.1016/j.heliyon.2024.e35208. eCollection 2024 Aug 15. Heliyon. 2024. PMID: 39170516 Free PMC article. Review. - The YTH domain-containing protein family: Emerging players in immunomodulation and tumour immunotherapy targets.
Li F, Zeng C, Liu J, Wang L, Yuan X, Yuan L, Xia X, Huang W. Li F, et al. Clin Transl Med. 2024 Aug;14(8):e1784. doi: 10.1002/ctm2.1784. Clin Transl Med. 2024. PMID: 39135292 Free PMC article. Review.
References
- Cell. 2009 Aug 21;138(4):645-659 - PubMed
- Curr Stem Cell Res Ther. 2009 May;4(2):147-53 - PubMed
- Cell. 2010 May 14;141(4):583-94 - PubMed
- Nat Rev Clin Oncol. 2011 Feb;8(2):97-106 - PubMed
- Nat Rev Cancer. 2006 Feb;6(2):146-55 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous